<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-144001</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Secondary prevention of ischemic non cardioembolic stroke</dc:title>
<dc:description xml:lang="en">Stroke patients are at high risk for recurrence or new occurrence of other cardiovascular events or cardiovascular mortality. It is estimated that a high percentage of non-cardioembolic ischemic stroke can be prevented by a suitable modification of lifestyle (diet and exercise), reducing blood pressure (BP) with antihypertensive medication, platelet aggregation inhibitors, statins and high intake reducing consumption of. Unfortunately the degree of control of the different risk factors in secondary prevention of stroke is low. The clinical practice guidelines show clear recommendations with corresponding levels of evidence, but only if implemented in a general way they will get a better primary and secondary stroke prevention (AU)</dc:description>
<dc:creator>Pedro Armario, Pedro</dc:creator>
<dc:creator>Cardona, Pere</dc:creator>
<dc:creator>Pinto, Xavier</dc:creator>
<dc:creator>Soler, Cristina</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los pacientes con ictus presentan un elevado riesgo de sufrir nuevas recurrencias o aparición de otros episodios cardiovasculares o de mortalidad cardiovascular. Se estima que un porcentaje elevado de ictus isquémicos no cardioembólicos pueden ser prevenido mediante un adecuada modificación del estilo de vida (dieta y ejercicio), reducción de la presión arterial (PA) con medicación antihipertensiva, antiagregantes plaquetarios, estatinas y reducción del consumo elevado de alcohol. Desgraciadamente el grado de control de los distintos factores de riesgo en la prevención secundaria del ictus es muy bajo. Las guías de practica clínica, muestran recomendaciones claras, con sus correspondientes niveles de evidencia, pero solo si se implementan de un forma general conseguirán una mejor prevención primaria y secundaria del ictus (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);27(6): 287-300, nov.-dic. 2015. tab</dc:source>
<dc:identifier>ibc-144001</dc:identifier>
<dc:title xml:lang="es">Prevención secundaria del ictus isquémico no cardioembólico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7678^s22012</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d7678^s22054</dc:subject>
<dc:subject>^d2586^s22054</dc:subject>
<dc:subject>^d22965^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d7152^s22054</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d2359^s22054</dc:subject>
<dc:subject>^d7130^s22054</dc:subject>
<dc:subject>^d34247^s22054</dc:subject>
<dc:subject>^d34247^s22012</dc:subject>
<dc:subject>^d53393^s22066</dc:subject>
<dc:subject>^d962^s22073</dc:subject>
<dc:subject>^d53393^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201512</dc:date>
</metadata>
</record>
</ibecs-document>
